Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

Recruiting now · Not applicable

Conditions studied: Small-cell Lung Cancer

In brief

To assess the safety and efficacy of intensity-modulated proton therapy (IMPT) for small cell lung cancer (SCLC)

Key facts

Study ID

NCT04342429

Run by

Emory University

People needed

30

Starts

2020-03-19

Expected to finish

2027-05-27

Last updated by the study team

2025-07-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Pathologically confirmed small cell lung cancer, limited or extensive stage.
• Patients who are offered thoracic radiotherapy with intensity-modulated proton therapy (IMPT) techniques delivering 30-66 Gy in 15-33 fractions at 2 Gy per fraction, at the recommendation of the treating radiation oncologist.
• Age 18 or greater

You may not qualify if…

• Prior radiation therapy which would provide significant dose overlap with the planned target volume(s)
• Pregnancy

Where it is running

• Winship Cancer Institute — Atlanta, Georgia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.